276
Participants
Start Date
September 19, 2019
Primary Completion Date
July 29, 2022
Study Completion Date
July 29, 2022
Vibegron
oral administration
AccuMed Research Associates, Garden City
Urological Surgeons of Long Island, Garden City
Urology Center Of Florida, Pompano Beach
Quantum Clinical Trials, Miami
Precision Clinical Research, Sunrise
Imagine Research of Palm Beach County - Urology, Boynton Beach
Tampa Bay Medical Research, Clearwater
Clinical Research of Central Florida, Winter Haven
Private Practice, Huntsville
Clinical Research Solutions, Middleburg Heights
Beaumont Hospital Royal Oak - Urology Research, Royal Oak
CentraCare Clinic - Adult & Pediatric Urology, Sartell
Poplar Bluff Urology, Poplar Bluff
Adult & Pediatric Urology P.C. - Urology, Omaha
DelRicht Research, New Orleans
Regional Urology, LLC, Shreveport
Advances In Health, Inc., Houston
Wasatch Clinical Research LLC, Salt Lake City
Excel Clinical Research - Internal Medicine, Las Vegas
Private Practice, Las Vegas
American Institute of Research, Los Angeles
Skyline Urology, Torrance
San Diego Clinical Trials, San Diego
Tri Valley Urology Medical Group, Murrieta
Clinical Trials Research, Lincoln
Northern California Research Corp, Sacramento
Seattle Urology Research Center, Burien
Boston Clinical Trials Inc - Urology, Boston
Bay State Clinical Trials, Inc., Watertown
Premier Urology Group, LLC, Edison
New Jersey Urology NJU, Englewood
Centrum Medyczne Linden, Krakow
Centrum Medyczne PROMED, Krakow
Medicome Sp. z o.o., Oświęcim
Nzoz Heureka, Piaseczno
Urovant Sciences GmbH
INDUSTRY